CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in GMAB — Genmab A/S

CIK 884546 SAN FRANCISCO, CA

Position in GMAB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,422,729

+$10,120 QoQ

Shares Held

127,571

+15.1% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 99.84008904845145.ToString("F0")% Shared 0.ToString("F0")% None 0.15991095154854945.ToString("F0")%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. GMAB ranks #149 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,422,729	127,571	+15.1%	Shares	Sole	2026-05-15
2025-12-31	$3,412,609	110,799	+9.5%	Shares	Sole	2026-02-13
2025-09-30	$3,103,159	101,179	+32.3%	Shares	Sole	2025-11-10
2025-06-30	$1,580,304	76,491	+59.8%	Shares	Sole	2025-08-12
2025-03-31	$937,372	47,874	-21.7%	Shares	Sole	2025-09-15
2024-12-31	$1,276,763	61,177	+134.4%	Shares	Sole	2025-02-06
2024-09-30	$636,415	26,104	+94.1%	Shares	Sole	2024-11-12
2024-06-30	$337,998	13,450	-50.7%	Shares	Sole	2024-08-12
2024-03-31	$815,944	27,280	+58.4%	Shares	Sole	2024-05-09
2023-12-31	$548,444	17,225	-6.1%	Shares	Sole	2024-02-06
2023-09-30	$646,851	18,340	+146.2%	Shares	Sole	2023-11-08
2023-06-30	$283,136	7,449	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.